nafagrel has been researched along with Asthma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrawal, DK; Ono, S; Takami, M | 1 |
| Takami, M; Tsukada, W | 1 |
| Matsumoto, K; Ono, S; Takami, M; Takata, Y; Tsukada, W | 1 |
3 other study(ies) available for nafagrel and Asthma
| Article | Year |
|---|---|
A novel thromboxane synthetase inhibitor, DP-1904, inhibits human blood eosinophil degranulation.
Topics: Asthma; Blood Proteins; Cell Degranulation; Cell Separation; Drug Evaluation; Eosinophil Granule Proteins; Eosinophils; Humans; Hypersensitivity, Immediate; Imidazoles; Ribonucleases; Tetrahydronaphthalenes; Thromboxane-A Synthase | 1997 |
Correlative alteration of thromboxane A2 with antigen-induced bronchoconstriction and the role of platelets as a source of TXA2 synthesis in guinea pigs: effect of DP-1904, an inhibitor of thromboxane synthetase.
Topics: Animals; Anti-Asthmatic Agents; Antigens; Asthma; Blood Platelets; Enzyme Inhibitors; Guinea Pigs; Imidazoles; Male; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase | 1998 |
Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antigens; Asthma; Bronchoconstriction; Guinea Pigs; Imidazoles; In Vitro Techniques; Lung; Ovalbumin; Tetrahydronaphthalenes; Thromboxane B2; Thromboxane-A Synthase | 1991 |